6个美国成年人中有1个患有哮喘,由于费用高,药量过量,因此有可能受到更多的攻击。 One in six U.S. adults with asthma skips meds due to costs, risking more attacks.

大约六分之一患有哮喘的美国成年人买不起处方药, 导致哮喘发作和紧急探诊的风险较高。 About one in six U.S. adults with asthma can't afford their medications as prescribed, leading to higher risks of asthma attacks and emergency visits. 尽管成本从2011年的23%下降到2022年的13%,但成本仍然是一个障碍,对妇女、黑人个人和18-60岁的人来说尤其如此。 Despite a decline from 23% in 2011 to 13% in 2022, cost remains a barrier, especially for women, Black individuals, and those aged 18-60. 这项为期 12 年的研究发表在 Thorax 上，强调了提高药物可负担性的必要性。 The study, covering 12 years and published in Thorax, highlights the need for better medication affordability.